Cargando…
A protease activity-based machine-learning approach as a complementary tool for conventional diagnosis of diarrhea-predominant irritable bowel syndrome
Irritable bowel syndrome (IBS) has no clinically accepted biomarkers even though it affects a large number of individuals worldwide. To address this lack of understanding, we evaluated peptidase activity in fecal samples from 35 patients with diarrheal IBS without symptom exacerbation (IBS-n) and 35...
Autores principales: | Tanaka, Kazuki, Tanigawa, Naoki, Song, Isaiah, Komatsu, Toru, Kuriki, Yugo, Tanaka, Yukari, Fukudo, Shin, Urano, Yasuteru, Fukuda, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361618/ https://www.ncbi.nlm.nih.gov/pubmed/37485510 http://dx.doi.org/10.3389/fmicb.2023.1179534 |
Ejemplares similares
-
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation
por: Tanaka, Yukari, et al.
Publicado: (2022) -
Biopsychosocial Model of Irritable Bowel Syndrome
por: Tanaka, Yukari, et al.
Publicado: (2011) -
Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012) -
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016) -
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)